Chlorityle Capsule contains Chloramphenicol 500mg, a broad-spectrum antibiotic widely used for the treatment of serious bacterial infections. It works by inhibiting bacterial protein synthesis, effectively controlling the growth and spread of Gram-positive and Gram-negative bacteria.
The formulation is highly effective in managing infections such as typhoid, meningitis, respiratory tract infections, and ocular bacterial infections, ensuring rapid and reliable clinical outcomes. Chloramphenicol 500mg Capsule is suitable for both hospital and outpatient treatment settings, offering flexibility in therapeutic use.
Belonging to the anti-infective and antibiotic segment, Chlorityle Capsule is in strong demand among hospitals, clinics, and PCD pharma franchise networks. Its proven efficacy, versatility, and established clinical profile make it a trusted choice for healthcare providers.
For PCD franchise partners, Chlorityle Capsule represents a high-demand, profitable opportunity. Its wide application across multiple bacterial infections, combined with robust B2B distribution potential, ensures consistent business growth and attractive margins in both domestic and export markets.